David L. Ashley, PhD, Director, Office of Science
David L. Ashley, Ph.D. is currently Director of the Office of Science at the Center for Tobacco Products (CTP) of the U.S. Food and Drug Administration. He was appointed to that position in June 2010. The Office of Science at CTP is responsible for identifying, developing, and enhancing the science related to tobacco products, their use, and the resulting morbidity and mortality so that regulatory decisions will have the greatest impact on improving public health. To accomplish this goal they provide the scientific support for regulations and guidance, review tobacco product applications, evaluate the knowledge basis for regulatory decisions, and carry out research to fill the gaps in scientific knowledge related to tobacco product regulation. He received his Ph.D. in Physical Chemistry from Emory University in Atlanta, Georgia in 1982.
Before taking on his current position at FDA, Dr. Ashley worked at the U.S. Centers for Disease Control and Prevention starting in 1983. At CDC, Dr. Ashley directed a branch of 87 scientists with a diverse public health mission including biomarkers of heavy metals, measurement of biomarkers of volatile organic compounds, biomarkers of tobacco use, and analysis of chemical constituents of tobacco products. He has performed extensive research related to the impact of cigarette design and contents on the emissions from tobacco products, how people use the product and resulting biomarkers of exposure. He has published over 140 peer-reviewed articles and book chapters related to biophysics, environmental chemicals, biomarkers of exposure and the constituents of tobacco and tobacco smoke. He was a contributing author for the recent Surgeon General's Report entitled How Tobacco Causes Disease--The Biology and Behavioral Basis for Tobacco-Attributable Disease. He has presented extensively at scientific meetings on the chemistry of tobacco and tobacco smoke and biomarkers of exposure. Dr. Ashley serves on the World Health Organization (WHO) Study Group for Tobacco Product Regulation and was the Chair of the WHO Tobacco Laboratory Network from 2006 until 2010.